Mabylon AG
Bettina Mathis is a Research Associate who has worked at Mabylon AG since July 2017 and previously at ImmunoQure Research AG from 2014 to July 2017.
This person is not in any teams
Mabylon AG
Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.